Get the Stockscreener App
7.84
5.66%
-0.47
After Hours:
7.84
Elicio Therapeutics Inc Stock (ELTX) Forecast
The Elicio Therapeutics Inc (ELTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.0881, representing a -9.59% decrease from the current price of $7.84. The highest analyst price target is $7.9631, and the lowest is $6.2132.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELTX Price Target
Average 7.348
(-6.28% Downside)
Is Elicio Therapeutics Inc (ELTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.05 | Neutral |
| STOCH(9,6) | 44.16 | Neutral |
| STOCHRSI(14) | 67.74 | Neutral |
| MACD(12,26) | 0.2008 | Sell |
| ADX(14) | 24.99 | Neutral |
| William %R | -71.26 | Neutral |
| CCI(14) | -13.31 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.205
Sell
|
8.1878
Sell
|
| MA20 |
8.365
Sell
|
8.1212
Sell
|
| MA50 |
7.1453
Buy
|
7.3801
Buy
|
| MA100 |
6.021
Buy
|
6.5974
Buy
|
| MA200 |
5.8086
Buy
|
6.1629
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ELTX could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ELTX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.05 indicates that ELTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 44.16 indicates that ELTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.74 indicates that ELTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.99 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.31 indicates that ELTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ELTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Elicio Therapeutics Inc financial reports and earnings history, Elicio Therapeutics Inc (ELTX) stock could reach $12.43 by 2030, $15.46 by 2040 and $16.35 by 2050. See the projected annual prices until 2050 of the Elicio Therapeutics Inc stock below:
- Elicio Therapeutics Inc (ELTX) is expected to reach an average price of $12.07 in 2035, with a high prediction of $13.73 and a low estimate of $11.28. This indicates an $53.95% rise from the last recorded price of $7.84.
- Elicio Therapeutics Inc (ELTX) stock is projected to chart a bullish course in 2040, with an average price target of $10.13, representing an $29.27% surge from its current level. The forecast ranges from a conservative $9.7444 to a sky-high $15.46.
- Our analysts predict Elicio Therapeutics Inc (ELTX) to jump 81.18% by 2045, soaring from $13.80 to an average price of $14.20, potentially reaching $16.44. While $13.80 is the low estimate, the potential upside is significant.
- Elicio Therapeutics Inc (ELTX) stock is expected to climb by 2050, reaching an average of $12.55, a $60.14% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.35 and $10.98, respectively, highlighting the market's uncertainty.
Elicio Therapeutics Inc Stock (ELTX) Year by Year Forecast
Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2025
Elicio Therapeutics Inc Stock (ELTX) is expected to reach an average price of $7.2316 in 2025, with a high prediction of $11.04 and a low estimate of $3.4277. This indicates an -7.76% fall from the last recorded price of $7.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $6.3734 | $6.2132 | $7.9631 | -18.71% |
| May, 2025 | $6.4546 | $5.6537 | $7.4646 | -17.67% |
| June, 2025 | $7.5658 | $5.9252 | $11.04 | -3.50% |
| July, 2025 | $4.8674 | $3.5168 | $8.5861 | -37.92% |
| August, 2025 | $4.5286 | $3.4277 | $4.968 | -42.24% |
| September, 2025 | $7.2898 | $4.3489 | $7.5898 | -7.02% |
| October, 2025 | $9.4614 | $6.7701 | $10.91 | +20.68% |
| November, 2025 | $8.4505 | $8.0455 | $10.69 | +7.79% |
| December, 2025 | $6.7528 | $6.7528 | $10.32 | -13.87% |
Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2026
The predicted value for Elicio Therapeutics Inc (ELTX) in 2026 is set at an average of $7.5813. Estimates vary from a peak of $11.50 to a trough of $3.6615, indicating an -3.30% surge from the present price of $7.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.5646 | $6.4447 | $8.1946 | -16.27% |
| February, 2026 | $6.5864 | $5.8855 | $7.1955 | -15.99% |
| March, 2026 | $9.0383 | $6.1578 | $11.27 | +15.28% |
| April, 2026 | $5.1006 | $3.7501 | $9.1287 | -34.94% |
| May, 2026 | $4.8024 | $3.6615 | $5.351 | -38.74% |
| June, 2026 | $5.7043 | $4.3129 | $6.4243 | -27.24% |
| July, 2026 | $9.1066 | $6.1047 | $11.14 | +16.16% |
| August, 2026 | $9.54 | $9.047 | $10.61 | +21.68% |
| September, 2026 | $7.4431 | $7.1131 | $10.92 | -5.06% |
| October, 2026 | $7.4355 | $6.9837 | $8.4237 | -5.16% |
| November, 2026 | $7.078 | $6.1174 | $8.4261 | -9.72% |
| December, 2026 | $9.271 | $6.3904 | $11.50 | +18.25% |
Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Elicio Therapeutics Inc (ELTX) is $7.8146, with a high forecast of $11.73 and a low forecast of $3.8953. This indicates an -0.32% decrease from the last price of $7.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.5535 | $3.9835 | $9.3617 | -29.16% |
| February, 2027 | $5.096 | $3.8953 | $5.8841 | -35.00% |
| March, 2027 | $5.939 | $4.5472 | $6.659 | -24.25% |
| April, 2027 | $10.79 | $6.3396 | $10.84 | +37.65% |
| May, 2027 | $10.15 | $8.9221 | $11.38 | +29.47% |
| June, 2027 | $8.6531 | $8.0631 | $11.15 | +10.37% |
| July, 2027 | $7.8761 | $7.2146 | $8.6546 | +0.46% |
| August, 2027 | $7.1592 | $6.3492 | $8.6577 | -8.68% |
| September, 2027 | $7.613 | $6.585 | $8.4123 | -2.89% |
| October, 2027 | $5.8561 | $5.4361 | $11.73 | -25.30% |
| November, 2027 | $5.3492 | $4.1292 | $6.1176 | -31.77% |
| December, 2027 | $6.093 | $4.7815 | $6.323 | -22.28% |
Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2028
In 2028, Elicio Therapeutics Inc (ELTX) is projected to reach an average price of $8.1648, with a high projection of $11.97 and a low estimate of $4.363. This indicates an +4.14% rise from the last price of $7.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.03 | $5.8048 | $10.20 | +27.88% |
| February, 2028 | $10.38 | $9.1576 | $11.61 | +32.39% |
| March, 2028 | $9.8328 | $8.7359 | $11.38 | +25.42% |
| April, 2028 | $7.7864 | $7.4455 | $10.10 | -0.68% |
| May, 2028 | $7.391 | $6.581 | $8.8892 | -5.73% |
| June, 2028 | $7.9547 | $6.817 | $8.6447 | +1.46% |
| July, 2028 | $6.6384 | $6.2484 | $11.97 | -15.33% |
| August, 2028 | $5.583 | $4.363 | $7.0793 | -28.79% |
| September, 2028 | $5.5567 | $5.0158 | $5.9039 | -29.12% |
| October, 2028 | $9.0104 | $5.3755 | $9.2104 | +14.93% |
| November, 2028 | $10.61 | $7.9333 | $11.85 | +35.40% |
| December, 2028 | $9.4221 | $8.9661 | $11.61 | +20.18% |
Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2029
The 2029 price forecast for Elicio Therapeutics Inc Stock (ELTX) is $8.3981 on average, with a high prediction of $12.20 and a low estimate of $4.5968. This represents an +7.12% increase from the previous price of $7.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.0175 | $7.6764 | $11.24 | +2.26% |
| February, 2029 | $7.5318 | $7.3708 | $9.1207 | -3.93% |
| March, 2029 | $7.6161 | $6.8129 | $8.6261 | -2.86% |
| April, 2029 | $8.7304 | $7.0883 | $12.20 | +11.36% |
| May, 2029 | $6.0358 | $4.6836 | $9.7515 | -23.01% |
| June, 2029 | $5.7001 | $4.5968 | $6.1379 | -27.30% |
| July, 2029 | $8.4644 | $5.5211 | $8.7644 | +7.96% |
| August, 2029 | $10.64 | $7.9454 | $12.09 | +35.71% |
| September, 2029 | $9.6012 | $9.1962 | $11.84 | +22.46% |
| October, 2029 | $7.9074 | $7.9074 | $11.47 | +0.86% |
| November, 2029 | $7.7223 | $7.6024 | $9.3523 | -1.50% |
| December, 2029 | $7.7472 | $7.0447 | $8.3547 | -1.18% |
Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2030
Elicio Therapeutics Inc Stock (ELTX) is expected to reach an average price of $8.7478 in 2030, with a high forecast of $12.66 and a low forecast of $4.8307. This signifies an +11.58% surge from the last price of $7.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.9633 | $7.3209 | $12.43 | +14.33% |
| February, 2030 | $6.2682 | $4.917 | $9.9845 | -20.05% |
| March, 2030 | $5.9731 | $4.8307 | $6.5195 | -23.81% |
| April, 2030 | $6.878 | $5.4844 | $7.598 | -12.27% |
| May, 2030 | $10.28 | $7.2793 | $12.32 | +31.18% |
| June, 2030 | $10.69 | $10.23 | $11.79 | +36.35% |
| July, 2030 | $8.5969 | $8.2669 | $12.07 | +9.65% |
| August, 2030 | $8.5924 | $8.1383 | $9.5783 | +9.60% |
| September, 2030 | $8.238 | $7.2766 | $9.5838 | +5.08% |
| October, 2030 | $10.43 | $7.5535 | $12.66 | +33.10% |
| November, 2030 | $6.7204 | $5.1504 | $10.53 | -14.28% |
| December, 2030 | $6.2659 | $5.0645 | $7.0518 | -20.08% |
3.13%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):